Italy: Sputnik V demonstrates almost 100% efficacy, San Marino institute says
ROME, August 10. /TASS/: Antibodies to coronavirus after receiving a second dose of the Russian Sputnik V vaccine were developed by 99% of the participants of a joint study by San Marino’s government and Italy’s Lazzaro Spallanzani National Institute for Infectious Diseases, representative of San Marino’s Institute for Social Security Franco Cavalli told TASS.